Skip to content

Better Evaluation of Acute Chest Pain With Computed Tomography Angiography

Better Evaluation of Acute Chest Pain With Computed Tomography Angiography - A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01413282
Acronym
BEACON
Enrollment
500
Registered
2011-08-10
Start date
2011-07-31
Completion date
2015-02-28
Last updated
2016-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Acute Chest Pain

Keywords

Acute coronary syndrome

Brief summary

The purpose of this study is to determine whether cardiac CT can improve triage of acute chest pain patients in the emergency department.

Detailed description

Myocardial infarction remains one of the most important causes of death and disability. Therefore it is important that individuals with acute chest pain are accurately assessed without delaying appropriate treatment. Acute coronary syndrome is only one cause for sudden chest pain, which is a very common complaint in the ER. Other life threatening causes such as pulmonary embolism and aortic dissection may also be the cause, although most chest discomfort has a benign reason (musculoskeletal, hyperventilation, oesophageal reflux, etc). The current work-up of suspected acute coronary syndrome, based on presentation, symptoms, ECG and biomarkers, is not efficient and results in unnecessary diagnostics and hospital admissions, as well as errors or delayed diagnoses, in a substantial number of patients. Computed tomography angiography (CTA) images atherosclerosis, coronary obstruction as well as myocardial hypoperfusion. We hypothesize that early use of CTA is of incremental value and allows for accurate and immediate triage of patients with acute chest pain.

Interventions

RADIATIONCardiac CT

Calcium scan and CT coronary angiography

Sponsors

Erasmus Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Acute chest pain or equivalent * Patients older than 30 years * Males \< 75 years and Females \< 80 years

Exclusion criteria

* STEMI * Troponin \> 0.1 * History of known myocardial infarction, PCI or CABG * Pregnancy * Contrast allergy * Renal disfunction * No informed consent possible * No follow-up possible

Design outcomes

Primary

MeasureTime frameDescription
Successful discharge rate30 daysThe proportion of patients discharged home without major adverse events during the following 30 days. Major adverse events are cardiovascular death or non-fatal myocardial infarction.
Diagnostic yield of invasive angiography30 daysNumber of patients identified with severe coronary artery disease identified by invasive angiography requiring revascularisation according to the international guidelines.

Secondary

MeasureTime frameDescription
Acute coronary syndromeIndex hospital visitDiagnosis of acute coronary syndrome, according to international guidelines, at time of discharge.
Missed myocardial infarctions2 daysMissed myocardial infarctions, at 2-day follow-up, in patients discharged from the emergency department.
Duration of hospital stayIndex hospital visitDuration of hospital stay
Successful discharge rate for all adverse events30 daysThe proportion of patients discharged home without any adverse events during the following 30 days. Adverse events are cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularization, repeat hospital visits for chest pain.
Radiation exposure6 monthsCumulative medical radiation exposure at 6 months.
Renal function2 daysChange in renal function after 2 days.
Direct medical cost30 daysDirect medical costs until 30th day after ED visit.
Major adverse events6 monthsComposite endpoint of major adverse cardiac events at 6 months: cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularisation and repeat hospital visits for chest pain.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026